M
RMD icon

Mirova’s ResMed RMD Stock Holding History

Mirova’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-416
Closed -$93.1K – 136
2025
Q1 		$93.1K Hold
416
– – 0.02% 124
2024
Q4 		$95.1K Sell
416
-18
-4% -$4.33K 0.02% 119
2024
Q3 		$106K Hold
434
– – 0.02% 113
2024
Q2 		$83.1K Buy
434
+121
+39% +$24.6K 0.02% 117
2024
Q1 		$62K Hold
313
– – 0.01% 128
2023
Q4 		$53.8K Sell
313
-18
-5% -$2.77K 0.01% 123
2023
Q3 		$48.9K Sell
331
-514
-61% -$92.9K 0.01% 125
2023
Q2 		$185K Sell
845
-896
-51% -$200K 0.03% 122
2023
Q1 		$381K Buy
+1,741
New +$378K 0.06% 123
2022
Q4 		– Sell
-1,215
Closed -$265K – 190
2022
Q3 		$265K Sell
1,215
-3,552
-75% -$808K 0.04% 138
2022
Q2 		$999K Buy
+4,767
New +$1.01M 0.14% 89

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Mirova's RMD Position: Q2 2025 in Review

Mirova sold out of ResMed (RMD) in Q2 2025, closing a stake of 416 shares — an estimated $93.1K sold.

Mirova first reported a position in RMD in Q2 2022 and held it in 11 quarters. The position peaked at $999K in Q2 2022. 919 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

  • Mirova reported no remaining ResMed position as of Q2 2025 after selling out during the quarter.
  • Mirova sold 416 ResMed shares in Q2 2025, an estimated $93.1K.
  • Mirova first reported a position in ResMed in Q2 2022 and held it in 11 quarters.
  • Mirova's ResMed position peaked at $999K in Q2 2022.
  • 919 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on Mirova's 13F filing for Q2 2025, filed 13 Aug 2025.